We then assessed the capability of the RT-LAMP assay to amplify SARS-CoV-2 105 nucleic acid directly from raw sample matrix consisting of nasopharyngeal swabs from 106 asymptomatic donors placed in universal transport medium (UTM) or phosphate 107 buffered saline (PBS) and spiked with SARS-CoV-2 IVT target RNA.